{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:54:31Z","timestamp":1790405671402,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s11864-009-0108-2","type":"journal-article","created":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T18:25:38Z","timestamp":1247595938000},"page":"67-81","source":"Crossref","is-referenced-by-count":70,"title":["Current Understanding of Risk Factors for Ovarian Cancer"],"prefix":"10.1007","volume":"10","author":[{"given":"Thanasak","family":"Sueblinvong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,15]]},"reference":[{"key":"108_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jekmal","year":"2008","unstructured":"Jekmal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008,58:71-96.","journal-title":"CA Cancer J Clin"},{"key":"108_CR2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bpobgyn.2005.10.016","volume":"20","author":"L Hanna","year":"2006","unstructured":"Hanna L, Adams M. Prevention of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2006,20:339-362.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1155\/2007\/474320","volume":"23","author":"SC Mok","year":"2007","unstructured":"Mok SC, Kwong J, Welch WR, et al. Etiology and pathogenesis of epithelial ovarian cancer. Disease Markers 2007,23:367-376.","journal-title":"Dis Markers"},{"key":"108_CR4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF. Incessant ovulation\u2014a factor in ovarian neoplasia? Lancet 1971, 2:163.","journal-title":"Lancet"},{"key":"108_CR5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2265.1998.00577.x","volume":"49","author":"T Riman","year":"1998","unstructured":"Riman T, Persson I, Nilsson S.: Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.Clin Endocrinol 1998,49:695-707.","journal-title":"Clin Endocrinol"},{"key":"108_CR6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1525-1438.2006.00749.x","volume":"17","author":"H Zheng","year":"2007","unstructured":"Zheng H, Kavanagh JJ, Hu W, et al.: Hormonal therapy in ovarian cancer. Int J Gynecol Cancer 2007,17:325-338.","journal-title":"Int J Gynecol Cancer"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","volume":"90","author":"HA Risch","year":"1998","unstructured":"Risch HA.: Hormonal etiology of epithelial ovarian cancer with a hypothesis concerning the role of androgen and progesterone. J Natl Cancer Inst 1998, 90:1774-1786.","journal-title":"J Natl Cancer Inst"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","volume":"11","author":"RB Ness","year":"2000","unstructured":"Ness RB, Griss JA, Cottreau C, et al.: Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000,11:111-117.","journal-title":"Epidemiology"},{"key":"108_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/17.1.221","volume":"17","author":"DW Cramer","year":"2002","unstructured":"Cramer DW, Barbieri RL, Fraer AR, Harlow BL.: Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age. Hum Reprod 2002,17:221-227.","journal-title":"Hum Reprod"},{"key":"108_CR10","first-page":"711","volume":"71","author":"DW Cramer","year":"1983","unstructured":"Cramer DW, Hutchison GB, Welch WR, et al.: Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983,71:711-716.","journal-title":"J Natl Cancer Inst"},{"key":"108_CR11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00001648-199911000-00018","volume":"10","author":"L Wittenberg","year":"1999","unstructured":"Wittenberg L, Cook LS, Rossing MA, Weiss NS.: Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer. Epidemiology 1999,10:761-763.","journal-title":"Epidemiology"},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(94)90749-8","volume":"344","author":"HO Adami","year":"1994","unstructured":"Adami HO, Hsieh CC, Lambe M, et al.: Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994,344:1250-1254.","journal-title":"Lancet"},{"key":"108_CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","volume":"156","author":"T Riman","year":"2002","unstructured":"Riman T, Dickman PW, Nilsson S, et al.: Risk factors for invasive epithelial ovarian cancer: result from a Swedish case-control study. Am J Epidemiol 2002,156:363-373.","journal-title":"Am J Epidemiol"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J:. Characteristics relating to ovarian cancer risk; collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992,136:1184-1203.","journal-title":"Am J Epidemiol"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.aje.a117296","volume":"140","author":"HA Risch","year":"1994","unstructured":"Risch HA, Marrett LD, Howe GR.: Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994,140:585-597.","journal-title":"Am J Epidemiol"},{"key":"108_CR16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.2910620606","volume":"62","author":"D Purdie","year":"1995","unstructured":"Purdie D, Green A, Bain C, et al.: Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women\u2019s Health Study Group. Int J Cancer 1995,62:678-684.","journal-title":"Int J Cancer"},{"key":"108_CR17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","volume":"60","author":"M Booth","year":"1989","unstructured":"Booth M, Beral V, Smith P.: Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989;60:592-598.","journal-title":"Br J Cancer"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ijc.2910550312","volume":"55","author":"A Polychronopoulou","year":"1993","unstructured":"Polychronopoulou A, Tzonou A, Hsieh CC, et al.: Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer 1993,55:402-407.","journal-title":"Int J Cancer"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/gyno.2001.6451","volume":"83","author":"T Riman","year":"2001","unstructured":"Riman T, Dickman PW, Nilsson S, et al.: Risk factors of epithelial borderine ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 2001,83:575-585.","journal-title":"Gynecol Oncol"},{"key":"108_CR20","first-page":"5849","volume":"48","author":"BL Harlow","year":"1988","unstructured":"Harlow BL, Weiss NS, Roth GJ, et al.: Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. Cancer Res 1988,48:5849-5852.","journal-title":"Cancer Res"},{"key":"108_CR21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ije\/20.4.871","volume":"20","author":"F Parazzine","year":"1991","unstructured":"Parazzine F, Restelli C, La Vecchia C, et al.: Risk factors for epithelial ovarian tumours of borderline malignancy. Int J Epidemiol 1991,20:871-877.","journal-title":"Int J Epidemiol"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/oxfordjournals.aje.a116428","volume":"136","author":"R Harris","year":"1992","unstructured":"Harris R, Whittemore AS, Itnyre J.: Characteristic relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992,136:1204-1211.","journal-title":"Am J Epidemiol"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a008937","volume":"144","author":"HA Risch","year":"1996","unstructured":"Risch HA, Marrett LD, Jain M, Howe GR.: Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case-control study. Am J Epidemiol 1996,144:363-372.","journal-title":"Am J Epidemiol"},{"key":"108_CR24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1055-9965.EPI-08-0390","volume":"17","author":"S Cnattingius","year":"2008","unstructured":"Cnattingius S, Eloranta S, Adami HO, et al.: Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset. Cancer Epidemiol Biomarkers Prev 2008,17:2344-2349.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1055-9965.EPI-06-0962","volume":"16","author":"LA Mucci","year":"2007","unstructured":"Mucci LA, Dickman PW, Lambe M, et al.: Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort. Cancer Epidemiol Biomarkers Prev 2007,16:1828-1832.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/1097-0142(20001015)89:8<1783::AID-CNCR19>3.0.CO;2-D","volume":"89","author":"K Munstedt","year":"2000","unstructured":"Munstedt K, Steen J, Knauf AG, et al.: Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 2000,89:1783-1791.","journal-title":"Cancer"},{"key":"108_CR27","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<1944::AID-CNCR15>3.0.CO;2-V","volume":"79","author":"SZ Bu","year":"1997","unstructured":"Bu SZ, Yin DL, Ren XH, et al.: Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 1997,79:1944-1950.","journal-title":"Cancer"},{"key":"108_CR28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ijc.10613","volume":"101","author":"A Lukanova","year":"2000","unstructured":"Lukanova A, Lundin E, Toniolo P, et al.: Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2000,101:549-554.","journal-title":"Int J Cancer"},{"key":"108_CR29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10552-007-0130-2","volume":"18","author":"KN Danforth","year":"2007","unstructured":"Danforth KN, Tworoger SS, Hecht JL, et al.: Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control 2007, 18:517-523.","journal-title":"Cancer Causes Control"},{"key":"108_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5","volume":"76","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE, Colditz GA, Hunter DJ, et al.: A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 1995,76:284-290.","journal-title":"Cancer"},{"key":"108_CR31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwn006","volume":"167","author":"PG Moorman","year":"2008","unstructured":"Moorman PG, Calingaert B, Palmieri RT, et al.: Hormonal risk factors for postmenopausal women. Am J Epidemiol 2008,167:1059-1069.","journal-title":"Am J Epidemiol"},{"key":"108_CR32","first-page":"708","volume":"80","author":"SE Hankinson","year":"1992","unstructured":"Hankinson SE, Colditz GA, Hunter DJ, et al.: A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol 1992,80: 708-714.","journal-title":"Obstet Gynecol"},{"key":"108_CR33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a117055","volume":"139","author":"L Rosenberg","year":"1994","unstructured":"Rosenberg L, Palmer JR, Zauber AG, et al.: A case-control study of oral contraception use and invasive epithelial ovarian cancer. Am J Epidemiol 1994,139:654-655.","journal-title":"Am J Epidemiol"},{"key":"108_CR34","doi-asserted-by":"crossref","unstructured":"The Cancer and Steroid Hormone (CASH) Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987, 316:650\u2013655","DOI":"10.1056\/NEJM198703123161102"},{"key":"108_CR35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0010-7824(91)90003-X","volume":"43","author":"JL Stanford","year":"1991","unstructured":"Stanford JL. Oral contraceptives and neoplasia of the ovary. Contraception 1991,43:543-556.","journal-title":"Contraception"},{"key":"108_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijc.2910490112","volume":"49","author":"S Franceschi","year":"1991","unstructured":"Franceschi S. Parazzini F, Negri E, et al. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer. III. Oral contraceptive use. Int J Cancer 1991,49:61-5.","journal-title":"Int J Cancer"},{"key":"108_CR37","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/sj.bjc.6604392","volume":"98","author":"KJ Wernli","year":"2008","unstructured":"Wernli KJ, Newcomb PA, Hampton JM, et al.: Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer 2008,98:1781-1783.","journal-title":"Br J Cancer"},{"key":"108_CR38","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1471-0528.1982.tb05067.x","volume":"89","author":"PN Bamford","year":"1982","unstructured":"Bamford PN, Seele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotropin therapy. Case report. Br J Obstet Gynaecol 1982,89:962-964.","journal-title":"Br J Obstet Gynaecol"},{"key":"108_CR39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0015-0282(16)58557-4","volume":"66","author":"RE Bristow","year":"1996","unstructured":"Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996,66:499-507.","journal-title":"Fertil Steril"},{"key":"108_CR40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(16)58020-0","volume":"65","author":"A Shushan","year":"1996","unstructured":"Shushan A, Paltiel O, Iscovich J, et al.: Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996,65:13-18.","journal-title":"Fertil Steril"},{"key":"108_CR41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(95)91687-3","volume":"346","author":"A Venn","year":"1995","unstructured":"Venn A, Watson L, Lumley J, et al.: Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 1995,346:995-1000.","journal-title":"Lancet"},{"key":"108_CR42","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/oxfordjournals.humrep.a138771","volume":"9","author":"S Franceschi","year":"1994","unstructured":"Franceschi S, La Vecchia C, Negri E, et al.: Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994,9:1673-1675.","journal-title":"Hum Reprod"},{"key":"108_CR43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/aje\/kwn318","volume":"169","author":"R Calderon-Margalit","year":"2009","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R, et al.: Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 2008, Nov 26. Epub 2008 Nov 26. Cited in PubMed; PMID 19037008","journal-title":"Am J Epidemiol"},{"key":"108_CR44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0015-0282(97)81431-8","volume":"67","author":"BJ Mosgaard","year":"1997","unstructured":"Mosgaard BJ, Lidegaard O, Kjaer SK, et al.: Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997,67:1005-1012.","journal-title":"Fertil Steril"},{"key":"108_CR45","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/oxfordjournals.aje.a115186","volume":"129","author":"LA Brinton","year":"1989","unstructured":"Brinton LA, Melton LJ, Malkasian GD, et al.: Cancer risk after evaluation for infertility. Am J Epidemiol 1989,129:712-722.","journal-title":"Am J Epidemiol"},{"key":"108_CR46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","volume":"331","author":"MA Rossing","year":"1994","unstructured":"Rossing MA, Daling JR, Weiss NS, et al.: Ovarian tumors in a cohort of infertile women. N Engl J Med 1994,331:771-776.","journal-title":"N Engl J Med"},{"key":"108_CR47","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/oxfordjournals.aje.a114595","volume":"125","author":"E Ron","year":"1987","unstructured":"Ron E, Lunenfeld B, Menczer J, et al.: Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987,125:780-790.","journal-title":"Am J Epidemiol"},{"key":"108_CR48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/humrep\/den358","volume":"24","author":"G Chene","year":"2009","unstructured":"Chene G, Penault-Llorca F, Le Bouedec G, et al.: Ovarian epithelial dysplasia after ovulation induction: time and dose effects. Hum Reprod 2009,24:132-138.","journal-title":"Hum Reprod"},{"key":"108_CR49","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/oxfordjournals.aje.a114902","volume":"127","author":"P Hartge","year":"1988","unstructured":"Hartge P, Hoover R, McGowan L, et al.: Menopause and ovarian cancer. Am J Epidemiol 1988,127:990-998.","journal-title":"Am J Epidemiol"},{"key":"108_CR50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0029-7844(97)00118-X","volume":"89","author":"RE Hempling","year":"1997","unstructured":"Hempling RE, Wong C, Piver MS, et al.: Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. Obstet Gynecol 1997,89:1012-1016.","journal-title":"Obstet Gynecol"},{"key":"108_CR51","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/oxfordjournals.aje.a115441","volume":"130","author":"DW Kaufman","year":"1989","unstructured":"Kaufman DW, Kelly JP, Welch WR, et al.: Noncontraceptive estrogen use and epithelial ovarian cancer. Am J Epidemiol 1989,130:1142-1151.","journal-title":"Am J Epidemiol"},{"key":"108_CR52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.1996.0315","volume":"63","author":"HA Risch","year":"1996","unstructured":"Risch HA.: Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecol Oncol 1996,63:254-257.","journal-title":"Gynecol Oncol"},{"key":"108_CR53","first-page":"472","volume":"92","author":"PP Garg","year":"1998","unstructured":"Garg PP, Kerlikowske K, Subak L, Grady D.: Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998,92:472-479.","journal-title":"Obstet Gynecol"},{"key":"108_CR54","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","volume":"285","author":"C Rodriguez","year":"2001","unstructured":"Rodriguez C, Patel AV, Calle EE, et al.: Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. J Am Med Assoc 2001,285:1460-1465.","journal-title":"J Am Med Assoc"},{"key":"108_CR55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjc.6690731","volume":"81","author":"DM Purdie","year":"1999","unstructured":"Purdie DM, Bain CJ, Siskind C, et al.: Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer 1999,81:559-563.","journal-title":"Br J Cancer"},{"key":"108_CR56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","volume":"288","author":"JV Lacey","year":"2002","unstructured":"Lacey JV, Mink PJ, Lubin JH, et al.: Menopausal hormone replacement therapy and risk of ovarian cancer. J Am Med Assoc 2002,288:334-341.","journal-title":"J Am Med Assoc"},{"key":"108_CR57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/94.7.497","volume":"94","author":"T Riman","year":"2002","unstructured":"Riman T, Dickman PW, Nilsson S, et al.: Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 2002,94:497-505.","journal-title":"J Natl Cancer Inst"},{"key":"108_CR58","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","volume":"290","author":"GL Anderson","year":"2003","unstructured":"Anderson GL, Judd HL, Kaunitz AM, et al.: Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures. The Women\u2019s Health Initiative Randomized Trial. J Am Med Assoc 2003,290:1739-1748.","journal-title":"J Am Med Assoc"},{"key":"108_CR59","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/1055-9965.EPI-07-0550","volume":"16","author":"MA Rossing","year":"2007","unstructured":"Rossing MA, Cushing-Haugen KL, Wicklund KG, et al.: Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007,16:2548-2556.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1258\/136218003100322215","volume":"2","author":"T Riman","year":"2003","unstructured":"Riman T.: hormone replacement therapy and epithelial ovarian cancer: is there an association? J Br Menopause Soc 2003,2:61-68.","journal-title":"J Br Menopause Soc"},{"key":"108_CR61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.302.6771.259","volume":"302","author":"RA Eeles","year":"1991","unstructured":"Eeles RA, Tan S, Wiltshaw E, et al.: Hormone replacement therapy and survival after surgery for ovarian cancer. Br Med J 1991,302:259-262.","journal-title":"Br Med J"},{"key":"108_CR62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/1047-2797(94)00098-E","volume":"5","author":"DW Cramer","year":"1995","unstructured":"Cramer DW, Xu H. Epidemiologic evidence of uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol 1995,5:301-314.","journal-title":"Ann Epidemiol"},{"key":"108_CR63","first-page":"151","volume":"64","author":"J Halme","year":"1984","unstructured":"Halme J, Hammond MG, Hulka JF, et al.: Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984,64:151-154.","journal-title":"Obstet Gynecol"},{"key":"108_CR64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/oxfordjournals.aje.a009112","volume":"145","author":"HL Miracle-McMahill","year":"1997","unstructured":"Miracle-McMahill HL, Calle EE, Kosinski AS, et al.: Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol 1997,145:349-357.","journal-title":"Am J Epidemiol"},{"key":"108_CR65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<948::AID-IJC6>3.0.CO;2-Y","volume":"71","author":"A Green","year":"1997","unstructured":"Green A, Purdie D, Bain C, et al.: Tubal sterilization, hysterectomy and decreased risk of ovarian cancer. Int J Cancer 1997,71:948-951.","journal-title":"Int J Cancer"},{"key":"108_CR66","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1001\/jama.1993.03510230051034","volume":"270","author":"SE Hankinson","year":"1993","unstructured":"Hankinson SE, Hunter DJ, Colditz GA, et al.: Tubal ligation, hysterectomy and risk of ovarian cancer, a prospective study. J Am Med Assoc 1993,270:2813-2818.","journal-title":"J Am Med Assoc"},{"key":"108_CR67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1047-2797(99)00045-9","volume":"10","author":"CM Beard","year":"2000","unstructured":"Beard CM, Hartmann LC, Atkinson EJ, et al.: The epidemiology of ovarian cancer: a population-based study in Olmsted County, Minnesota, 1935\u20131991. Ann Epidemiol 2000,10:14-23.","journal-title":"Ann Epidemiol"},{"key":"108_CR68","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ije\/26.4.710","volume":"26","author":"N Kreiger","year":"1997","unstructured":"Kreiger N, Sloan M, Cotterchio M, Parsons P.: Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol 1997,26:710-715.","journal-title":"Int J Epidemiol"},{"key":"108_CR69","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10552-008-9207-9","volume":"19","author":"MA Rossing","year":"2008","unstructured":"Rossing MA, Cushing-Haugen KL, Wicklund KG, et al.: Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control 2008,19:1357-1364.","journal-title":"Cancer Causes Control"},{"key":"108_CR70","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9378(97)70550-7","volume":"176","author":"LA Brinton","year":"1997","unstructured":"Brinton LA, Gridley G, Persson I, et al.: Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997,176:572-579.","journal-title":"Am J Obstet Gynecol"},{"key":"108_CR71","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/gyno.2000.5765","volume":"77","author":"S Ogawa","year":"2000","unstructured":"Ogawa S, Kaku T, Amada S, et al.: Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000,77:298-304.","journal-title":"Gynecol Oncol"},{"key":"108_CR72","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1074-3804(05)60591-9","volume":"8","author":"K Takahashi","year":"2001","unstructured":"Takahashi K, Kurioka H, Irikoma M, et al.: Benign or malignant ovarian neoplasms and ovarian endometriomas. J Am Assoc Gynecol Laparosc 2001,8:278-284.","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"108_CR73","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/humrep\/dem209","volume":"22","author":"A Melin","year":"2007","unstructured":"Melin A, Sparen P, Bergqvist A.: The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007,22:3021-3026.","journal-title":"Hum Reprod"},{"key":"108_CR74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/gyno.2000.5905","volume":"79","author":"GM Zanetta","year":"2000","unstructured":"Zanetta Gm, Webb MJ, Li H, Keeney GL.: Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 2000,79:18-22.","journal-title":"Gynecol Oncol"},{"key":"108_CR75","first-page":"447","volume":"4","author":"HA Risch","year":"1995","unstructured":"Risch HA, Howe GR.: Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 1995,4:447-451.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR76","first-page":"667","volume":"5","author":"F Parazzini","year":"1996","unstructured":"Parazzini F, La Vecchia C, Negri E, et al.: Pelvic inflammatory disease and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 1996,5:667-669.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR77","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","volume":"7","author":"A Balen","year":"2001","unstructured":"Balen A.: Polycystic ovary syndrome and cancer. Hum Reprod Update 2001,7:522-525.","journal-title":"Hum Reprod Update"},{"key":"108_CR78","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","volume":"88","author":"JM Schuldkraut","year":"1996","unstructured":"Schuldkraut JM, Schwingl PJ, Bastos E, et al.: Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996,88:554-559.","journal-title":"Obstet Gynecol"},{"key":"108_CR79","first-page":"1955","volume":"23","author":"M Huncharek","year":"2003","unstructured":"Huncharek M, Geschwind JF, Kupelnick B. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies. Anticancer Res. 2003,23:1955-1960.","journal-title":"Anticancer Res"},{"key":"108_CR80","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/oxfordjournals.aje.a009128","volume":"145","author":"LS Cook","year":"1997","unstructured":"Cook LS, Kamb ML, Weiss NS.: Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 1997,145:459-465.","journal-title":"Am J Epidemiol"},{"key":"108_CR81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jnci\/92.3.249","volume":"92","author":"DM Gertig","year":"2000","unstructured":"Gertig DM, Hunter DJ, Cramer DW, et al.: Prospective study of talc use and ovarian cancer. J Natl Cancer Inst 2000,92:249-252.","journal-title":"J Natl Cancer Inst"},{"key":"108_CR82","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ijc.20434","volume":"112","author":"PK Mills","year":"2004","unstructured":"Mills PK, Riodan DG, Cress RD, Young HA.: Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California. Int J Cancer 2004,112:458-464.","journal-title":"Int J Cancer"},{"key":"108_CR83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/rtph.1995.1039","volume":"21","author":"BL Harlow","year":"1995","unstructured":"Harlow BL, Hartge PA. A review of perineal talc exposure and risk of ovarian cancer. Regul Toxicol Pharmacol 1995,21:254-260.","journal-title":"Regul Toxicol Pharmacol"},{"key":"108_CR84","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ptr.2117","volume":"21","author":"AR Buz\u2019Zard","year":"2007","unstructured":"Buz\u2019Zard AR, Lau BH.: Pycnogenol reduces talc-induced neoplastic transformation in human ovarian cell cultures. Phytother Res 2007,21:579-586.","journal-title":"Phytother Res"},{"key":"108_CR85","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1055-9965.EPI-08-0399","volume":"17","author":"MA Gates","year":"2008","unstructured":"Gates MA, Tworoger SS, Terry KL, et al. Talc use, variants of the GSTM1, GSTT, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008,17:2436-2444.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR86","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1055-9965.EPI-07-0089","volume":"16","author":"M Soegaard","year":"2007","unstructured":"Soegaard M, Jensen A, Hogdall E, et al.: Different risk factor profiles for mucinous and non-mucinous ovarian cancer: result from the Danish MALOVA Study. Cancer Epidemiol Biomarkers Prev 2007,16:1160-1166.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR87","first-page":"255","volume":"95","author":"PA Marchbanks","year":"2000","unstructured":"Marchbanks PA, Wilson H, Bastos E, et al.: Cigarette smoking and epithelial ovarian cancer by histology type. Obstet Gynecol 2000,95:255-260.","journal-title":"Obstet Gynecol"},{"key":"108_CR88","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10654-004-1633-8","volume":"19","author":"T Riman","year":"2004","unstructured":"Riman T, Dickman PW, Nilsson S, et al.: Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 2004,19:1011-1019.","journal-title":"Eur J Epidemiol"},{"key":"108_CR89","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ygyno.2006.08.012","volume":"103","author":"SJ Jordan","year":"2006","unstructured":"Jordan SJ, Whiteman DC, Purdie DM, et al. Does smoking increase risk of ovarian cancer? A systemic review. Gynecol Oncol 2006,103:1122-1129.","journal-title":"Gynecol Oncol"},{"key":"108_CR90","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ijc.1422","volume":"93","author":"C Bosetti","year":"2001","unstructured":"Bosetti C, Negri E, Franceschi S, et al.: Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 2001,93:911-915.","journal-title":"Int J Cancer"},{"key":"108_CR91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdn594","volume":"20","author":"V Edefonti","year":"2009","unstructured":"Edefonti V, Randi G, Decarli A, et al.: Clustering dietary habits and the risk of breast and ovarian cancers. Ann Oncol 2008, Oct 7. Epub 2008 Oct 7. Cited in PubMed; PMID 18842615","journal-title":"Ann Oncol"},{"key":"108_CR92","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2003.10.025","volume":"92","author":"M Zhang","year":"2004","unstructured":"Zhang M, Lee AH, Binns CW.: Reproductive and dietary risk factors for epithelial ovarian cancer in China. Gynecol Oncol 2004,92:320-326.","journal-title":"Gynecol Oncol"},{"key":"108_CR93","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1015047625060","volume":"13","author":"E Bidoli","year":"2002","unstructured":"Bidoli E, La Vecchia C, Montella M, et al.: Nutrient intake and ovarian cancer: an Italian case-control study. Cancer Causes Control 2002,13:255-261.","journal-title":"Cancer Causes Control"},{"key":"108_CR94","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1207\/S15327914nc391_3","volume":"39","author":"SE McCann","year":"2001","unstructured":"McCann SE, Moysich KB, Mettlin C.: Intakes of selected nutrients and food groups and risk of ovarian cancer. Nutr Cancer 2001,39:19-28.","journal-title":"Nutr Cancer"},{"key":"108_CR95","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1207\/S15327914NC402_3","volume":"40","author":"AT Fleischauer","year":"2001","unstructured":"Fleischauer AT, Olson SH, Mignone L, et al.: Dietary antioxidants, supplements and risk of epithelial ovarian cancer. Nutr Cancer 2001,40:92-98.","journal-title":"Nutr Cancer"},{"key":"108_CR96","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/cncr.21332","volume":"104","author":"M Mommers","year":"2005","unstructured":"Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA.: Consumption of vegetables and fruits and risk of ovarian cancer. Cancer 2005,104:1512-1519.","journal-title":"Cancer"},{"key":"108_CR97","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1158\/1055-9965.EPI-05-0218","volume":"14","author":"A Koushik","year":"2005","unstructured":"Koushik A, Hunter DJ, Spiegelman D, et al. Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2005,14:2160-2167.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR98","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000063814","volume":"63","author":"E Salazar-Martinez","year":"2002","unstructured":"Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, et al.: Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 2002,63:151-157.","journal-title":"Oncology"},{"key":"108_CR99","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.amepre.2006.08.018","volume":"31","author":"CF Garland","year":"2006","unstructured":"Garland CF, Mohr SB, Gorham ED, et al.: Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 2006,31:512-514.","journal-title":"Am J Prev Med"},{"key":"108_CR100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0090-8258(92)90028-H","volume":"44","author":"DE Saunders","year":"1992","unstructured":"Saunders DE, Christensen C, Lawrence WD, et al. Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms. Gynecol Oncol 1992,44:131-136.","journal-title":"Gynecol Oncol"},{"key":"108_CR101","doi-asserted-by":"crossref","first-page":"53213","DOI":"10.1074\/jbc.M410395200","volume":"279","author":"F Jiang","year":"2004","unstructured":"Jiang F, Bao J, Li P, et al.: Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down regulation of telomerase. J Biol Chem 2004,279:53213-53221.","journal-title":"J Biol Chem"},{"key":"108_CR102","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1078-0432.323.11.1","volume":"11","author":"X Zhang","year":"2005","unstructured":"Zhang X, Jiang F, Li p, et al. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089. Clin Cancer Res 2005,11:323-328.","journal-title":"Clin Cancer Res"},{"key":"108_CR103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pbiomolbio.2006.02.014","volume":"92","author":"MF Holick","year":"2006","unstructured":"Holick MF.: Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006,92:49-59.","journal-title":"Prog Biophys Mol Biol"},{"key":"108_CR104","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1158\/1055-9965.EPI-07-0753","volume":"16","author":"G Lurie","year":"2007","unstructured":"Lurie G, Wilkens LR, Thompson PJ, et al.: Vitamin D receptor gene polymorphism and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2007,16:2566-2571.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1210\/endo.141.4.7403","volume":"141","author":"K Kinuta","year":"2000","unstructured":"Kinuta K, Tanaka H, Moriwake T, et al.: Vitamin D is an important factor in estrogen biosynthesis of both female and male gonad. Endocrinology 2000,141:1317-1324.","journal-title":"Endocrinology"},{"key":"108_CR106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10552-006-0083-x","volume":"18","author":"ET Chang","year":"2007","unstructured":"Chang ET, Canchola AJ, Lee VS, et al.: Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control 2007,18:91-103.","journal-title":"Cancer Causes Control"},{"key":"108_CR107","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/ijc.22137","volume":"119","author":"NB Peterson","year":"2006","unstructured":"Peterson NB, Trentham-Dietz A, Newcomb PA.: Alcohol consumption and ovarian cancer in a population-based case-control study. Int J Cancer 2006,119:2423-2427.","journal-title":"Int J Cancer"},{"key":"108_CR108","first-page":"1336","volume":"102","author":"F Modugno","year":"2003","unstructured":"Modugno F, Ness RB, Allen GO.: Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer. Obstet Gynecol 2003,102:1336-1343.","journal-title":"Obstet Gynecol"},{"key":"108_CR109","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/1097-0215(20001015)88:2<313::AID-IJC26>3.0.CO;2-5","volume":"88","author":"H Kuper","year":"2000","unstructured":"Kuper H, Titus-Ernstoff L, Harlow BL.: Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000,88:313-318.","journal-title":"Int J Cancer"},{"key":"108_CR110","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-05-0280","volume":"14","author":"SC Larsson","year":"2005","unstructured":"Larsson SC, Wolk A. Coffee consumption is not associated with ovarian cancer incidence. Cancer Epidemiol Biomarkers Prev 2005,14:2273-2274.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR111","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/B:CACO.0000027482.00077.8b","volume":"15","author":"SJ Jordan","year":"2004","unstructured":"Jordan SJ, Purdie DM, Green AC, Webb PM.: Coffee, tea, and caffeine and risk of epithelial ovarian cancer. Cancer Causes Control 2004,15:359-365.","journal-title":"Cancer Causes Control"},{"key":"108_CR112","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/archinte.165.22.2683","volume":"165","author":"SC Larsson","year":"2005","unstructured":"Larsson SC, Wolk A.: Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med 2005,165:2683-2686.","journal-title":"Arch Intern Med"},{"key":"108_CR113","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bpobgyn.2005.10.010","volume":"20","author":"G Rieck","year":"2006","unstructured":"Rieck G, Fiander A. The effect of lifestyle factors on gynaecological cancer. Best Pract Res Ciln Obstet Gynaecol 2006,20:227-251.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"108_CR114","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejca.2006.11.010","volume":"43","author":"CM Olsen","year":"2007","unstructured":"Olsen CM, Green AC, Whiteman DC, et al. :. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 2007,43:690-709.","journal-title":"Eur J Cancer"},{"key":"108_CR115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R","volume":"18","author":"AC Antoniou","year":"2000","unstructured":"Antoniou AC, Gayther SA, Stratton JF, et al.: Risk models for familial ovarian and breast cancer. Genet Epidemiol 2000,18:173-190.","journal-title":"Genet Epidemiol"},{"key":"108_CR116","first-page":"1","volume":"38","author":"NM Lindor","year":"2008","unstructured":"Lindor NM, McMaster ML, Lindor CJ, Greene MH.: Concise handbook of familial cancer susceptibility syndromes\u2014second edition. J Natl Cancer Inst Monogr 2008,38:1-93.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"108_CR117","first-page":"1287","volume":"10","author":"AB Spurdle","year":"2001","unstructured":"Spurdle AB, Hoppor JL, Chen X, et al.: The steroid 5 alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. Cancer Epidemiol Biomarkers Prev 2001,10:1287-1293.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR118","first-page":"3058","volume":"62","author":"EI Garner","year":"2002","unstructured":"Garner EI, Stokes EE, Berkowitz RS, et al.: Polymorphisms of estrogen-metabolizing genes CYP 17 and catechol-o-methyltransferase and risk of epithelial ovarian cancer. Cancer Res 2002,62:3058-3062.","journal-title":"Cancer Res"},{"key":"108_CR119","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1055-9965.EPI-08-0145","volume":"17","author":"G Lurie","year":"2008","unstructured":"Lurie G, Wilkens LR, Thompson PJ, et al.: Genetic polymorphisms in the Paraoxonase I gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev 2008,17:2070-2077.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"108_CR120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10552-008-9216-8","volume":"20","author":"G Lurie","year":"2009","unstructured":"Lurie G, Wilkens LR, Thompson PJ, et al.: Genetic polymorphism in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Cancer Causes Control 2008, Aug 15. Epub 2008 Aug 15. Cited in PubMed; PMID 18704709","journal-title":"Cancer Causes Control"},{"key":"108_CR121","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1677\/ERC-08-0104","volume":"15","author":"MT Goodman","year":"2008","unstructured":"Goodman MT, Laurie G, Thompson PJ, et al. Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk. Endocr Relat Cancer 2008,15:1055-1060.","journal-title":"Endocr Relat Cancer"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-009-0108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-009-0108-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-009-0108-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:37:59Z","timestamp":1685061479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-009-0108-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":121,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s11864-009-0108-2","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}